OT: Blume/Mutschler [R for BE/BA]

posted by nobody – 2019-04-25 13:43 (444 d 13:58 ago) – Posting: # 20234
Views: 5,006
(edited by nobody on 2019-04-25 15:11)

Yepp, I know the story around that in detail ;-) It was a move to couple science with politics (health care, pharmacists positioning as the "medicines expert"). Unfortunately this didn't work out, nowadays the health insurance buys the cheapest and decides which generic the patient gets. It's a shame...

RE: Replies from manufacturers. Not that different from today. In EU you still have only patchy Ass Reps from EMA, compared to the data released by FDA on products after MA granted.

Selling BE-studies+product was a fine business model for some time, some guys got rich and big with that. Quality of data has been an issue as long as there is any data around.... ;-)
—
Kindest regards, nobody

Complete thread:

Activity
 Admin contact
20,822 posts in 4,356 threads, 1,448 registered users;
online 14 (0 registered, 14 guests [including 8 identified bots]).
Forum time: 03:41 UTC (Europe/Vienna)

The analysis of variance is not a mathematical theorem,
but rather a convenient method of arranging the arithmetic.    R.A. Fisher

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5